So I was browsing around the internet looking for information about amg509 (a BiTE molecule) and discovered that it has a name now.
Xaluritamig
In Amgens financial report it says that “Initial data demonstrating responses will be presented at an upcoming medical congress.”
amgen.com/newsroom/press-re...
“Initial data demonstrating responses will be presented at an upcoming medical congress.”
They will do that at the ESMO Congress on the 20th of October 2023.
esmo.org/meeting-calendar/e...
Reply (1)Report
Together with arx517….let’s hope for the best!
Reply (1)Report
Just waiting patiently for a drug that is 99% effective at putting P cancer into remission.
Reply (1)Report
What did I expect short of a new meds tonged twister named Xaluritamig ..... that's right an announcement by our astute member: sszyszkiewicz.
Good Luck, Good Health and Good Humor.
j-o-h-n Saturday 10/15/2023 10:38 PM DST
Reply (1)Report
Hidden • in reply toj-o-h-n 1 year ago Clearly not named by someone in marketing
Reply (1)Report
mypk • in reply toHidden 1 year ago Most pharma companies, including Amgen, employ the 'Brand Institute' to assign names to their products. 'Xaluritamig' is no exception. 🙂
brandinstitute.com/experien...
Reply (0)Report